Abbott ID now molecular analyzers and reagents
Ended Definitive Contract Awarded Last action
- Contract number
- HT940825CE001
- Awardee
-
Abbott Rapid DX North America LLC UEI P782RNU1NNK3 Part of Abbott Laboratories Inc.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $503,212
Award facts
- Opportunity
-
- Womack Army Medical Center Nutrition Care Services Pre-Solicitation · HT940825R0001 · Posted Sep 5, 2025
- Contract value 20% obligated
-
- $1,006,424.00 Current, with exercised options
- $2,516,060.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Lockhart, FL 32810, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $503,212 | |
| Original award | $0 |
About this award
The Defense Health Agency awarded a $2.516 million definitive contract to Abbott Rapid DX North America LLC for Abbott ID NOW molecular analyzers and reagents on October 1, 2025, with performance through September 30, 2030.
Place of performance is Lockhart, FL. The contract is firm fixed price with no set-aside applied. Abbott Rapid DX North America LLC operates as a subsidiary of Abbott Laboratories Inc. and competes in the open market without SBA certifications, supplying point-of-care diagnostic testing devices and molecular diagnostic platforms to federal healthcare agencies. The vendor's federal footprint centers on COVID-19 and infectious-disease point-of-care testing, with primary concentration among Defense Logistics Agency Medical Supply Chain customers. Abbott Rapid DX holds a GSA Schedule 65-VII contract for in vitro diagnostics, reagents, and tests and operates primarily under DLA indefinite delivery vehicles. The awardee's work in this space includes hundreds of prior delivery orders for ID NOW rapid diagnostic tests, BinaxNOW COVID-19 antigen test cards, and related consumables, typically valued between $600 and $69,600 per order, alongside larger indefinite delivery contracts supporting federal laboratories and Veterans Integrated Service Network operations nationwide.
Quick answers
Who was awarded contract HT940825CE001?
HT940825CE001 was awarded to Abbott Rapid DX North America LLC by Defense Health Agency (Department of Defense) on October 1, 2025.
How much is contract HT940825CE001 worth?
The government has obligated $503,212 on HT940825CE001. Its current value, with exercised options, is $1,006,424. Its potential value, with all options, is $2,516,060.
Was contract HT940825CE001 competed?
The extent of competition for HT940825CE001 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award